Other
This product scores low due to weak scientific backing for its methylation panel's wellness claims. Key genes like MTHFR have common variants (e.g., C677T in 30-40% populations) but ACMG (2013) and recent reviews (PubMed 2024) find no clinical utility for thrombophilia, recurrent pregnancy loss, or general health risks; supplementation (methylfolate) not superior to standard folic acid per evidence. Panels promise personalized nutrition but lack RCTs showing outcomes better than generic advice.
Avoid this overpriced test with unproven wellness claims. Methylation genotyping offers limited actionable insights beyond standard nutrition advice. Opt for cheaper, broader DTC tests like 23andMe or consult a genetic counselor for real needs.